Global Avastin Biosimilar Supply, Demand and Key Producers, 2023-2029
The global Avastin Biosimilar market size is expected to reach $ 484.9 million by 2029, rising at a market growth of -13.9% CAGR during the forecast period (2023-2029).
Avastin Biosimilar is a humanized monoclonal antibody. It inhibits angiogenesis (the formation of new blood vessels) by blocking the action of vascular endothelial growth factor A (VEGF-A). Bevacizumab can therefore slow the growth of new blood vessels in tumours and is used to treat various cancers, including colorectal, lung, breast, glioblastoma, kidney and ovarian.
This report studies the global Avastin Biosimilar production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Avastin Biosimilar, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Avastin Biosimilar that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Avastin Biosimilar total production and demand, 2018-2029, (K Units)
Global Avastin Biosimilar total production value, 2018-2029, (USD Million)
Global Avastin Biosimilar production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Avastin Biosimilar consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Avastin Biosimilar domestic production, consumption, key domestic manufacturers and share
Global Avastin Biosimilar production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Avastin Biosimilar production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Avastin Biosimilar production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Avastin Biosimilar market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Celltrion, Amneal, Pfizer and Amgen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Avastin Biosimilar market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Avastin Biosimilar Market, By Region:
1. How big is the global Avastin Biosimilar market?
2. What is the demand of the global Avastin Biosimilar market?
3. What is the year over year growth of the global Avastin Biosimilar market?
4. What is the production and production value of the global Avastin Biosimilar market?
5. Who are the key producers in the global Avastin Biosimilar market?
6. What are the growth factors driving the market demand?
Avastin Biosimilar is a humanized monoclonal antibody. It inhibits angiogenesis (the formation of new blood vessels) by blocking the action of vascular endothelial growth factor A (VEGF-A). Bevacizumab can therefore slow the growth of new blood vessels in tumours and is used to treat various cancers, including colorectal, lung, breast, glioblastoma, kidney and ovarian.
This report studies the global Avastin Biosimilar production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Avastin Biosimilar, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Avastin Biosimilar that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Avastin Biosimilar total production and demand, 2018-2029, (K Units)
Global Avastin Biosimilar total production value, 2018-2029, (USD Million)
Global Avastin Biosimilar production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Avastin Biosimilar consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Avastin Biosimilar domestic production, consumption, key domestic manufacturers and share
Global Avastin Biosimilar production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Avastin Biosimilar production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Avastin Biosimilar production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Avastin Biosimilar market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Celltrion, Amneal, Pfizer and Amgen, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Avastin Biosimilar market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Avastin Biosimilar Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 400mg
- 100mg
- Cancer
- Wet Age-related Macular Degeneration
- Other
- Celltrion
- Amneal
- Pfizer
- Amgen
1. How big is the global Avastin Biosimilar market?
2. What is the demand of the global Avastin Biosimilar market?
3. What is the year over year growth of the global Avastin Biosimilar market?
4. What is the production and production value of the global Avastin Biosimilar market?
5. Who are the key producers in the global Avastin Biosimilar market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Avastin Biosimilar Introduction
1.2 World Avastin Biosimilar Supply & Forecast
1.2.1 World Avastin Biosimilar Production Value (2018 & 2022 & 2029)
1.2.2 World Avastin Biosimilar Production (2018-2029)
1.2.3 World Avastin Biosimilar Pricing Trends (2018-2029)
1.3 World Avastin Biosimilar Production by Region (Based on Production Site)
1.3.1 World Avastin Biosimilar Production Value by Region (2018-2029)
1.3.2 World Avastin Biosimilar Production by Region (2018-2029)
1.3.3 World Avastin Biosimilar Average Price by Region (2018-2029)
1.3.4 North America Avastin Biosimilar Production (2018-2029)
1.3.5 Europe Avastin Biosimilar Production (2018-2029)
1.3.6 China Avastin Biosimilar Production (2018-2029)
1.3.7 Japan Avastin Biosimilar Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Avastin Biosimilar Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Avastin Biosimilar Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Avastin Biosimilar Demand (2018-2029)
2.2 World Avastin Biosimilar Consumption by Region
2.2.1 World Avastin Biosimilar Consumption by Region (2018-2023)
2.2.2 World Avastin Biosimilar Consumption Forecast by Region (2024-2029)
2.3 United States Avastin Biosimilar Consumption (2018-2029)
2.4 China Avastin Biosimilar Consumption (2018-2029)
2.5 Europe Avastin Biosimilar Consumption (2018-2029)
2.6 Japan Avastin Biosimilar Consumption (2018-2029)
2.7 South Korea Avastin Biosimilar Consumption (2018-2029)
2.8 ASEAN Avastin Biosimilar Consumption (2018-2029)
2.9 India Avastin Biosimilar Consumption (2018-2029)
3 WORLD AVASTIN BIOSIMILAR MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Avastin Biosimilar Production Value by Manufacturer (2018-2023)
3.2 World Avastin Biosimilar Production by Manufacturer (2018-2023)
3.3 World Avastin Biosimilar Average Price by Manufacturer (2018-2023)
3.4 Avastin Biosimilar Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Avastin Biosimilar Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Avastin Biosimilar in 2022
3.5.3 Global Concentration Ratios (CR8) for Avastin Biosimilar in 2022
3.6 Avastin Biosimilar Market: Overall Company Footprint Analysis
3.6.1 Avastin Biosimilar Market: Region Footprint
3.6.2 Avastin Biosimilar Market: Company Product Type Footprint
3.6.3 Avastin Biosimilar Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Avastin Biosimilar Production Value Comparison
4.1.1 United States VS China: Avastin Biosimilar Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Avastin Biosimilar Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Avastin Biosimilar Production Comparison
4.2.1 United States VS China: Avastin Biosimilar Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Avastin Biosimilar Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Avastin Biosimilar Consumption Comparison
4.3.1 United States VS China: Avastin Biosimilar Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Avastin Biosimilar Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Avastin Biosimilar Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Avastin Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Avastin Biosimilar Production Value (2018-2023)
4.4.3 United States Based Manufacturers Avastin Biosimilar Production (2018-2023)
4.5 China Based Avastin Biosimilar Manufacturers and Market Share
4.5.1 China Based Avastin Biosimilar Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Avastin Biosimilar Production Value (2018-2023)
4.5.3 China Based Manufacturers Avastin Biosimilar Production (2018-2023)
4.6 Rest of World Based Avastin Biosimilar Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Avastin Biosimilar Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Avastin Biosimilar Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Avastin Biosimilar Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Avastin Biosimilar Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 400mg
5.2.2 100mg
5.3 Market Segment by Type
5.3.1 World Avastin Biosimilar Production by Type (2018-2029)
5.3.2 World Avastin Biosimilar Production Value by Type (2018-2029)
5.3.3 World Avastin Biosimilar Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Avastin Biosimilar Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Cancer
6.2.2 Wet Age-related Macular Degeneration
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Avastin Biosimilar Production by Application (2018-2029)
6.3.2 World Avastin Biosimilar Production Value by Application (2018-2029)
6.3.3 World Avastin Biosimilar Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Celltrion
7.1.1 Celltrion Details
7.1.2 Celltrion Major Business
7.1.3 Celltrion Avastin Biosimilar Product and Services
7.1.4 Celltrion Avastin Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Celltrion Recent Developments/Updates
7.1.6 Celltrion Competitive Strengths & Weaknesses
7.2 Amneal
7.2.1 Amneal Details
7.2.2 Amneal Major Business
7.2.3 Amneal Avastin Biosimilar Product and Services
7.2.4 Amneal Avastin Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Amneal Recent Developments/Updates
7.2.6 Amneal Competitive Strengths & Weaknesses
7.3 Pfizer
7.3.1 Pfizer Details
7.3.2 Pfizer Major Business
7.3.3 Pfizer Avastin Biosimilar Product and Services
7.3.4 Pfizer Avastin Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Pfizer Recent Developments/Updates
7.3.6 Pfizer Competitive Strengths & Weaknesses
7.4 Amgen
7.4.1 Amgen Details
7.4.2 Amgen Major Business
7.4.3 Amgen Avastin Biosimilar Product and Services
7.4.4 Amgen Avastin Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Amgen Recent Developments/Updates
7.4.6 Amgen Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Avastin Biosimilar Industry Chain
8.2 Avastin Biosimilar Upstream Analysis
8.2.1 Avastin Biosimilar Core Raw Materials
8.2.2 Main Manufacturers of Avastin Biosimilar Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Avastin Biosimilar Production Mode
8.6 Avastin Biosimilar Procurement Model
8.7 Avastin Biosimilar Industry Sales Model and Sales Channels
8.7.1 Avastin Biosimilar Sales Model
8.7.2 Avastin Biosimilar Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Avastin Biosimilar Introduction
1.2 World Avastin Biosimilar Supply & Forecast
1.2.1 World Avastin Biosimilar Production Value (2018 & 2022 & 2029)
1.2.2 World Avastin Biosimilar Production (2018-2029)
1.2.3 World Avastin Biosimilar Pricing Trends (2018-2029)
1.3 World Avastin Biosimilar Production by Region (Based on Production Site)
1.3.1 World Avastin Biosimilar Production Value by Region (2018-2029)
1.3.2 World Avastin Biosimilar Production by Region (2018-2029)
1.3.3 World Avastin Biosimilar Average Price by Region (2018-2029)
1.3.4 North America Avastin Biosimilar Production (2018-2029)
1.3.5 Europe Avastin Biosimilar Production (2018-2029)
1.3.6 China Avastin Biosimilar Production (2018-2029)
1.3.7 Japan Avastin Biosimilar Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Avastin Biosimilar Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Avastin Biosimilar Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Avastin Biosimilar Demand (2018-2029)
2.2 World Avastin Biosimilar Consumption by Region
2.2.1 World Avastin Biosimilar Consumption by Region (2018-2023)
2.2.2 World Avastin Biosimilar Consumption Forecast by Region (2024-2029)
2.3 United States Avastin Biosimilar Consumption (2018-2029)
2.4 China Avastin Biosimilar Consumption (2018-2029)
2.5 Europe Avastin Biosimilar Consumption (2018-2029)
2.6 Japan Avastin Biosimilar Consumption (2018-2029)
2.7 South Korea Avastin Biosimilar Consumption (2018-2029)
2.8 ASEAN Avastin Biosimilar Consumption (2018-2029)
2.9 India Avastin Biosimilar Consumption (2018-2029)
3 WORLD AVASTIN BIOSIMILAR MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Avastin Biosimilar Production Value by Manufacturer (2018-2023)
3.2 World Avastin Biosimilar Production by Manufacturer (2018-2023)
3.3 World Avastin Biosimilar Average Price by Manufacturer (2018-2023)
3.4 Avastin Biosimilar Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Avastin Biosimilar Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Avastin Biosimilar in 2022
3.5.3 Global Concentration Ratios (CR8) for Avastin Biosimilar in 2022
3.6 Avastin Biosimilar Market: Overall Company Footprint Analysis
3.6.1 Avastin Biosimilar Market: Region Footprint
3.6.2 Avastin Biosimilar Market: Company Product Type Footprint
3.6.3 Avastin Biosimilar Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Avastin Biosimilar Production Value Comparison
4.1.1 United States VS China: Avastin Biosimilar Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Avastin Biosimilar Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Avastin Biosimilar Production Comparison
4.2.1 United States VS China: Avastin Biosimilar Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Avastin Biosimilar Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Avastin Biosimilar Consumption Comparison
4.3.1 United States VS China: Avastin Biosimilar Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Avastin Biosimilar Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Avastin Biosimilar Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Avastin Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Avastin Biosimilar Production Value (2018-2023)
4.4.3 United States Based Manufacturers Avastin Biosimilar Production (2018-2023)
4.5 China Based Avastin Biosimilar Manufacturers and Market Share
4.5.1 China Based Avastin Biosimilar Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Avastin Biosimilar Production Value (2018-2023)
4.5.3 China Based Manufacturers Avastin Biosimilar Production (2018-2023)
4.6 Rest of World Based Avastin Biosimilar Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Avastin Biosimilar Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Avastin Biosimilar Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Avastin Biosimilar Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Avastin Biosimilar Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 400mg
5.2.2 100mg
5.3 Market Segment by Type
5.3.1 World Avastin Biosimilar Production by Type (2018-2029)
5.3.2 World Avastin Biosimilar Production Value by Type (2018-2029)
5.3.3 World Avastin Biosimilar Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Avastin Biosimilar Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Cancer
6.2.2 Wet Age-related Macular Degeneration
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Avastin Biosimilar Production by Application (2018-2029)
6.3.2 World Avastin Biosimilar Production Value by Application (2018-2029)
6.3.3 World Avastin Biosimilar Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Celltrion
7.1.1 Celltrion Details
7.1.2 Celltrion Major Business
7.1.3 Celltrion Avastin Biosimilar Product and Services
7.1.4 Celltrion Avastin Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Celltrion Recent Developments/Updates
7.1.6 Celltrion Competitive Strengths & Weaknesses
7.2 Amneal
7.2.1 Amneal Details
7.2.2 Amneal Major Business
7.2.3 Amneal Avastin Biosimilar Product and Services
7.2.4 Amneal Avastin Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Amneal Recent Developments/Updates
7.2.6 Amneal Competitive Strengths & Weaknesses
7.3 Pfizer
7.3.1 Pfizer Details
7.3.2 Pfizer Major Business
7.3.3 Pfizer Avastin Biosimilar Product and Services
7.3.4 Pfizer Avastin Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Pfizer Recent Developments/Updates
7.3.6 Pfizer Competitive Strengths & Weaknesses
7.4 Amgen
7.4.1 Amgen Details
7.4.2 Amgen Major Business
7.4.3 Amgen Avastin Biosimilar Product and Services
7.4.4 Amgen Avastin Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Amgen Recent Developments/Updates
7.4.6 Amgen Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Avastin Biosimilar Industry Chain
8.2 Avastin Biosimilar Upstream Analysis
8.2.1 Avastin Biosimilar Core Raw Materials
8.2.2 Main Manufacturers of Avastin Biosimilar Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Avastin Biosimilar Production Mode
8.6 Avastin Biosimilar Procurement Model
8.7 Avastin Biosimilar Industry Sales Model and Sales Channels
8.7.1 Avastin Biosimilar Sales Model
8.7.2 Avastin Biosimilar Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Avastin Biosimilar Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Avastin Biosimilar Production Value by Region (2018-2023) & (USD Million)
Table 3. World Avastin Biosimilar Production Value by Region (2024-2029) & (USD Million)
Table 4. World Avastin Biosimilar Production Value Market Share by Region (2018-2023)
Table 5. World Avastin Biosimilar Production Value Market Share by Region (2024-2029)
Table 6. World Avastin Biosimilar Production by Region (2018-2023) & (K Units)
Table 7. World Avastin Biosimilar Production by Region (2024-2029) & (K Units)
Table 8. World Avastin Biosimilar Production Market Share by Region (2018-2023)
Table 9. World Avastin Biosimilar Production Market Share by Region (2024-2029)
Table 10. World Avastin Biosimilar Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Avastin Biosimilar Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Avastin Biosimilar Major Market Trends
Table 13. World Avastin Biosimilar Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Avastin Biosimilar Consumption by Region (2018-2023) & (K Units)
Table 15. World Avastin Biosimilar Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Avastin Biosimilar Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Avastin Biosimilar Producers in 2022
Table 18. World Avastin Biosimilar Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Avastin Biosimilar Producers in 2022
Table 20. World Avastin Biosimilar Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Avastin Biosimilar Company Evaluation Quadrant
Table 22. World Avastin Biosimilar Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Avastin Biosimilar Production Site of Key Manufacturer
Table 24. Avastin Biosimilar Market: Company Product Type Footprint
Table 25. Avastin Biosimilar Market: Company Product Application Footprint
Table 26. Avastin Biosimilar Competitive Factors
Table 27. Avastin Biosimilar New Entrant and Capacity Expansion Plans
Table 28. Avastin Biosimilar Mergers & Acquisitions Activity
Table 29. United States VS China Avastin Biosimilar Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Avastin Biosimilar Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Avastin Biosimilar Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Avastin Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Avastin Biosimilar Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Avastin Biosimilar Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Avastin Biosimilar Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Avastin Biosimilar Production Market Share (2018-2023)
Table 37. China Based Avastin Biosimilar Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Avastin Biosimilar Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Avastin Biosimilar Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Avastin Biosimilar Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Avastin Biosimilar Production Market Share (2018-2023)
Table 42. Rest of World Based Avastin Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Avastin Biosimilar Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Avastin Biosimilar Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Avastin Biosimilar Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Avastin Biosimilar Production Market Share (2018-2023)
Table 47. World Avastin Biosimilar Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Avastin Biosimilar Production by Type (2018-2023) & (K Units)
Table 49. World Avastin Biosimilar Production by Type (2024-2029) & (K Units)
Table 50. World Avastin Biosimilar Production Value by Type (2018-2023) & (USD Million)
Table 51. World Avastin Biosimilar Production Value by Type (2024-2029) & (USD Million)
Table 52. World Avastin Biosimilar Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Avastin Biosimilar Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Avastin Biosimilar Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Avastin Biosimilar Production by Application (2018-2023) & (K Units)
Table 56. World Avastin Biosimilar Production by Application (2024-2029) & (K Units)
Table 57. World Avastin Biosimilar Production Value by Application (2018-2023) & (USD Million)
Table 58. World Avastin Biosimilar Production Value by Application (2024-2029) & (USD Million)
Table 59. World Avastin Biosimilar Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Avastin Biosimilar Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Celltrion Basic Information, Manufacturing Base and Competitors
Table 62. Celltrion Major Business
Table 63. Celltrion Avastin Biosimilar Product and Services
Table 64. Celltrion Avastin Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Celltrion Recent Developments/Updates
Table 66. Celltrion Competitive Strengths & Weaknesses
Table 67. Amneal Basic Information, Manufacturing Base and Competitors
Table 68. Amneal Major Business
Table 69. Amneal Avastin Biosimilar Product and Services
Table 70. Amneal Avastin Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Amneal Recent Developments/Updates
Table 72. Amneal Competitive Strengths & Weaknesses
Table 73. Pfizer Basic Information, Manufacturing Base and Competitors
Table 74. Pfizer Major Business
Table 75. Pfizer Avastin Biosimilar Product and Services
Table 76. Pfizer Avastin Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Pfizer Recent Developments/Updates
Table 78. Amgen Basic Information, Manufacturing Base and Competitors
Table 79. Amgen Major Business
Table 80. Amgen Avastin Biosimilar Product and Services
Table 81. Amgen Avastin Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Global Key Players of Avastin Biosimilar Upstream (Raw Materials)
Table 83. Avastin Biosimilar Typical Customers
Table 84. Avastin Biosimilar Typical Distributors
Table 1. World Avastin Biosimilar Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Avastin Biosimilar Production Value by Region (2018-2023) & (USD Million)
Table 3. World Avastin Biosimilar Production Value by Region (2024-2029) & (USD Million)
Table 4. World Avastin Biosimilar Production Value Market Share by Region (2018-2023)
Table 5. World Avastin Biosimilar Production Value Market Share by Region (2024-2029)
Table 6. World Avastin Biosimilar Production by Region (2018-2023) & (K Units)
Table 7. World Avastin Biosimilar Production by Region (2024-2029) & (K Units)
Table 8. World Avastin Biosimilar Production Market Share by Region (2018-2023)
Table 9. World Avastin Biosimilar Production Market Share by Region (2024-2029)
Table 10. World Avastin Biosimilar Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Avastin Biosimilar Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Avastin Biosimilar Major Market Trends
Table 13. World Avastin Biosimilar Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Avastin Biosimilar Consumption by Region (2018-2023) & (K Units)
Table 15. World Avastin Biosimilar Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Avastin Biosimilar Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Avastin Biosimilar Producers in 2022
Table 18. World Avastin Biosimilar Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Avastin Biosimilar Producers in 2022
Table 20. World Avastin Biosimilar Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Avastin Biosimilar Company Evaluation Quadrant
Table 22. World Avastin Biosimilar Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Avastin Biosimilar Production Site of Key Manufacturer
Table 24. Avastin Biosimilar Market: Company Product Type Footprint
Table 25. Avastin Biosimilar Market: Company Product Application Footprint
Table 26. Avastin Biosimilar Competitive Factors
Table 27. Avastin Biosimilar New Entrant and Capacity Expansion Plans
Table 28. Avastin Biosimilar Mergers & Acquisitions Activity
Table 29. United States VS China Avastin Biosimilar Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Avastin Biosimilar Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Avastin Biosimilar Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Avastin Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Avastin Biosimilar Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Avastin Biosimilar Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Avastin Biosimilar Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Avastin Biosimilar Production Market Share (2018-2023)
Table 37. China Based Avastin Biosimilar Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Avastin Biosimilar Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Avastin Biosimilar Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Avastin Biosimilar Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Avastin Biosimilar Production Market Share (2018-2023)
Table 42. Rest of World Based Avastin Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Avastin Biosimilar Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Avastin Biosimilar Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Avastin Biosimilar Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Avastin Biosimilar Production Market Share (2018-2023)
Table 47. World Avastin Biosimilar Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Avastin Biosimilar Production by Type (2018-2023) & (K Units)
Table 49. World Avastin Biosimilar Production by Type (2024-2029) & (K Units)
Table 50. World Avastin Biosimilar Production Value by Type (2018-2023) & (USD Million)
Table 51. World Avastin Biosimilar Production Value by Type (2024-2029) & (USD Million)
Table 52. World Avastin Biosimilar Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Avastin Biosimilar Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Avastin Biosimilar Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Avastin Biosimilar Production by Application (2018-2023) & (K Units)
Table 56. World Avastin Biosimilar Production by Application (2024-2029) & (K Units)
Table 57. World Avastin Biosimilar Production Value by Application (2018-2023) & (USD Million)
Table 58. World Avastin Biosimilar Production Value by Application (2024-2029) & (USD Million)
Table 59. World Avastin Biosimilar Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Avastin Biosimilar Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Celltrion Basic Information, Manufacturing Base and Competitors
Table 62. Celltrion Major Business
Table 63. Celltrion Avastin Biosimilar Product and Services
Table 64. Celltrion Avastin Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Celltrion Recent Developments/Updates
Table 66. Celltrion Competitive Strengths & Weaknesses
Table 67. Amneal Basic Information, Manufacturing Base and Competitors
Table 68. Amneal Major Business
Table 69. Amneal Avastin Biosimilar Product and Services
Table 70. Amneal Avastin Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Amneal Recent Developments/Updates
Table 72. Amneal Competitive Strengths & Weaknesses
Table 73. Pfizer Basic Information, Manufacturing Base and Competitors
Table 74. Pfizer Major Business
Table 75. Pfizer Avastin Biosimilar Product and Services
Table 76. Pfizer Avastin Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Pfizer Recent Developments/Updates
Table 78. Amgen Basic Information, Manufacturing Base and Competitors
Table 79. Amgen Major Business
Table 80. Amgen Avastin Biosimilar Product and Services
Table 81. Amgen Avastin Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Global Key Players of Avastin Biosimilar Upstream (Raw Materials)
Table 83. Avastin Biosimilar Typical Customers
Table 84. Avastin Biosimilar Typical Distributors
LIST OF FIGURES
Figure 1. Avastin Biosimilar Picture
Figure 2. World Avastin Biosimilar Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Avastin Biosimilar Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Avastin Biosimilar Production (2018-2029) & (K Units)
Figure 5. World Avastin Biosimilar Average Price (2018-2029) & (US$/Unit)
Figure 6. World Avastin Biosimilar Production Value Market Share by Region (2018-2029)
Figure 7. World Avastin Biosimilar Production Market Share by Region (2018-2029)
Figure 8. North America Avastin Biosimilar Production (2018-2029) & (K Units)
Figure 9. Europe Avastin Biosimilar Production (2018-2029) & (K Units)
Figure 10. China Avastin Biosimilar Production (2018-2029) & (K Units)
Figure 11. Japan Avastin Biosimilar Production (2018-2029) & (K Units)
Figure 12. Avastin Biosimilar Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Avastin Biosimilar Consumption (2018-2029) & (K Units)
Figure 15. World Avastin Biosimilar Consumption Market Share by Region (2018-2029)
Figure 16. United States Avastin Biosimilar Consumption (2018-2029) & (K Units)
Figure 17. China Avastin Biosimilar Consumption (2018-2029) & (K Units)
Figure 18. Europe Avastin Biosimilar Consumption (2018-2029) & (K Units)
Figure 19. Japan Avastin Biosimilar Consumption (2018-2029) & (K Units)
Figure 20. South Korea Avastin Biosimilar Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Avastin Biosimilar Consumption (2018-2029) & (K Units)
Figure 22. India Avastin Biosimilar Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Avastin Biosimilar by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Avastin Biosimilar Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Avastin Biosimilar Markets in 2022
Figure 26. United States VS China: Avastin Biosimilar Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Avastin Biosimilar Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Avastin Biosimilar Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Avastin Biosimilar Production Market Share 2022
Figure 30. China Based Manufacturers Avastin Biosimilar Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Avastin Biosimilar Production Market Share 2022
Figure 32. World Avastin Biosimilar Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Avastin Biosimilar Production Value Market Share by Type in 2022
Figure 34. 400mg
Figure 35. 100mg
Figure 36. World Avastin Biosimilar Production Market Share by Type (2018-2029)
Figure 37. World Avastin Biosimilar Production Value Market Share by Type (2018-2029)
Figure 38. World Avastin Biosimilar Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Avastin Biosimilar Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Avastin Biosimilar Production Value Market Share by Application in 2022
Figure 41. Cancer
Figure 42. Wet Age-related Macular Degeneration
Figure 43. Other
Figure 44. World Avastin Biosimilar Production Market Share by Application (2018-2029)
Figure 45. World Avastin Biosimilar Production Value Market Share by Application (2018-2029)
Figure 46. World Avastin Biosimilar Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Avastin Biosimilar Industry Chain
Figure 48. Avastin Biosimilar Procurement Model
Figure 49. Avastin Biosimilar Sales Model
Figure 50. Avastin Biosimilar Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Figure 1. Avastin Biosimilar Picture
Figure 2. World Avastin Biosimilar Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Avastin Biosimilar Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Avastin Biosimilar Production (2018-2029) & (K Units)
Figure 5. World Avastin Biosimilar Average Price (2018-2029) & (US$/Unit)
Figure 6. World Avastin Biosimilar Production Value Market Share by Region (2018-2029)
Figure 7. World Avastin Biosimilar Production Market Share by Region (2018-2029)
Figure 8. North America Avastin Biosimilar Production (2018-2029) & (K Units)
Figure 9. Europe Avastin Biosimilar Production (2018-2029) & (K Units)
Figure 10. China Avastin Biosimilar Production (2018-2029) & (K Units)
Figure 11. Japan Avastin Biosimilar Production (2018-2029) & (K Units)
Figure 12. Avastin Biosimilar Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Avastin Biosimilar Consumption (2018-2029) & (K Units)
Figure 15. World Avastin Biosimilar Consumption Market Share by Region (2018-2029)
Figure 16. United States Avastin Biosimilar Consumption (2018-2029) & (K Units)
Figure 17. China Avastin Biosimilar Consumption (2018-2029) & (K Units)
Figure 18. Europe Avastin Biosimilar Consumption (2018-2029) & (K Units)
Figure 19. Japan Avastin Biosimilar Consumption (2018-2029) & (K Units)
Figure 20. South Korea Avastin Biosimilar Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Avastin Biosimilar Consumption (2018-2029) & (K Units)
Figure 22. India Avastin Biosimilar Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Avastin Biosimilar by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Avastin Biosimilar Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Avastin Biosimilar Markets in 2022
Figure 26. United States VS China: Avastin Biosimilar Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Avastin Biosimilar Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Avastin Biosimilar Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Avastin Biosimilar Production Market Share 2022
Figure 30. China Based Manufacturers Avastin Biosimilar Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Avastin Biosimilar Production Market Share 2022
Figure 32. World Avastin Biosimilar Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Avastin Biosimilar Production Value Market Share by Type in 2022
Figure 34. 400mg
Figure 35. 100mg
Figure 36. World Avastin Biosimilar Production Market Share by Type (2018-2029)
Figure 37. World Avastin Biosimilar Production Value Market Share by Type (2018-2029)
Figure 38. World Avastin Biosimilar Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Avastin Biosimilar Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Avastin Biosimilar Production Value Market Share by Application in 2022
Figure 41. Cancer
Figure 42. Wet Age-related Macular Degeneration
Figure 43. Other
Figure 44. World Avastin Biosimilar Production Market Share by Application (2018-2029)
Figure 45. World Avastin Biosimilar Production Value Market Share by Application (2018-2029)
Figure 46. World Avastin Biosimilar Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Avastin Biosimilar Industry Chain
Figure 48. Avastin Biosimilar Procurement Model
Figure 49. Avastin Biosimilar Sales Model
Figure 50. Avastin Biosimilar Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
